Raymond James & Associates’s Nuveen Core Equity Alpha Fund JCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.38M Sell
415,191
-27,368
-6% -$408K ﹤0.01% 1488
2024
Q2
$6.64M Buy
442,559
+7,985
+2% +$113K ﹤0.01% 1396
2024
Q1
$6.11M Sell
434,574
-3,094
-0.7% -$42.1K ﹤0.01% 1446
2023
Q4
$5.93M Buy
437,668
+16,135
+4% +$207K ﹤0.01% 1421
2023
Q3
$5.24M Buy
421,533
+23,950
+6% +$306K ﹤0.01% 1435
2023
Q2
$5.07M Buy
397,583
+6,776
+2% +$83.2K ﹤0.01% 1470
2023
Q1
$4.81M Buy
390,807
+19,508
+5% +$247K ﹤0.01% 1485
2022
Q4
$5.03M Buy
371,299
+31,358
+9% +$428K ﹤0.01% 1392
2022
Q3
$4.12M Buy
339,941
+6,358
+2% +$91.2K ﹤0.01% 1503
2022
Q2
$4.45M Buy
333,583
+7,528
+2% +$110K ﹤0.01% 1472
2022
Q1
$5.72M Sell
326,055
-5,395
-2% -$88.2K ﹤0.01% 1416
2021
Q4
$6.16M Buy
331,450
+10,642
+3% +$182K 0.01% 1414
2021
Q3
$5.49M Buy
320,808
+12,263
+4% +$208K ﹤0.01% 1443
2021
Q2
$5.07M Buy
308,545
+12,250
+4% +$197K ﹤0.01% 1485
2021
Q1
$4.51M Sell
296,295
-18,474
-6% -$267K ﹤0.01% 1482
2020
Q4
$4.43M Buy
314,769
+7,708
+3% +$103K ﹤0.01% 1408
2020
Q3
$3.93M Sell
307,061
-55,394
-15% -$710K ﹤0.01% 1359
2020
Q2
$4.42M Buy
362,455
+32,096
+10% +$383K 0.01% 1264
2020
Q1
$3.54M Buy
330,359
+4,908
+2% +$66.3K 0.01% 1239
2019
Q4
$4.76M Buy
325,451
+9,458
+3% +$136K 0.01% 1283
2019
Q3
$4.53M Buy
315,993
+9,316
+3% +$131K 0.01% 1288
2019
Q2
$4.31M Buy
306,677
+4,442
+1% +$61.5K 0.01% 1297
2019
Q1
$4.25M Buy
302,235
+11,547
+4% +$155K 0.01% 1274
2018
Q4
$3.5M Buy
290,688
+8,053
+3% +$109K 0.01% 1290
2018
Q3
$4.41M Sell
282,635
-22,192
-7% -$342K 0.01% 1296
2018
Q2
$4.46M Buy
304,827
+822
+0.3% +$12.3K 0.01% 1263
2018
Q1
$4.44M Buy
304,005
+4,408
+1% +$65.6K 0.01% 1218
2017
Q4
$4.37M Buy
299,597
+38,234
+15% +$600K 0.01% 1196
2017
Q3
$4.06M Buy
261,363
+2,585
+1% +$39.4K 0.01% 1190
2017
Q2
$3.79M Buy
258,778
+6,324
+3% +$91.2K 0.01% 1171
2017
Q1
$3.52M Sell
252,454
-10,843
-4% -$149K 0.01% 1198
2016
Q4
$3.44M Sell
263,297
-2,540
-1% -$33.6K 0.01% 1175
2016
Q3
$3.65M Sell
265,837
-16,825
-6% -$240K 0.01% 1106
2016
Q2
$3.9M Buy
282,662
+2,961
+1% +$40.3K 0.01% 986
2016
Q1
$3.81M Sell
279,701
-13,595
-5% -$179K 0.01% 962
2015
Q4
$4.18M Sell
293,296
-313
-0.1% -$4.47K 0.02% 891
2015
Q3
$4.05M Sell
293,609
-22,236
-7% -$345K 0.02% 848
2015
Q2
$5M Sell
315,845
-18,637
-6% -$312K 0.02% 816
2015
Q1
$5.73M Buy
334,482
+13,666
+4% +$237K 0.03% 676
2014
Q4
$5.61M Buy
320,816
+66,871
+26% +$1.16M 0.03% 627
2014
Q3
$4.36M Sell
253,945
-30,209
-11% -$542K 0.03% 698
2014
Q2
$5.16M Buy
284,154
+42,600
+18% +$752K 0.03% 621
2014
Q1
$4.23M Buy
241,554
+71,045
+42% +$1.22M 0.03% 647
2013
Q4
$2.9M Buy
170,509
+84,492
+98% +$1.38M 0.02% 767
2013
Q3
$1.33M Buy
86,017
+35,691
+71% +$561K 0.01% 1091
2013
Q2
$756K Buy
+50,326
New +$774K 0.01% 1306

Other funds holding JCE

Raymond James & Associates's JCE Position: Q3 2024 in Review

Raymond James & Associates reduced its Nuveen Core Equity Alpha Fund (JCE) stake by 6.2% in Q3 2024, selling an estimated $408K and leaving 415,191 shares worth $6.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Raymond James & Associates first reported a position in JCE in Q2 2013 and has held it in 46 quarters since. The position peaked at $6.64M in Q2 2024. 48 funds tracked by Wall St. Rank hold JCE as of Q3 2024.

  • Raymond James & Associates held 415,191 shares of Nuveen Core Equity Alpha Fund worth $6.38M as of Q3 2024.
  • Raymond James & Associates sold 27,368 Nuveen Core Equity Alpha Fund shares in Q3 2024, an estimated $408K.
  • Nuveen Core Equity Alpha Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1488 holding.
  • Raymond James & Associates first reported a position in Nuveen Core Equity Alpha Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Nuveen Core Equity Alpha Fund position peaked at $6.64M in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Nuveen Core Equity Alpha Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.